Recent Updates
Recently added Catalysts
TVTX Positive Sentiment

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Monday, October 12, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Travere Therapeutics announced the granting of inducement equity grants to 33 new employees on October 10, 2026. The grants include stock options for 36,000 shares and restricted stock units covering 142,580 shares. This initiative is part of the company's strategy to comply with Nasdaq listing rules.

Market Sentiment Analysis

POSITIVE FACTORS

  • Inducement grants could attract talented new employees.
  • The equity grants reflect confidence in the company's growth.
  • The move aligns with Nasdaq listing requirements.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+68%
120-day peak, hindsight
Typical move
8.6%
average across 10 past catalysts
Lead asset
Sparsentan
Phase 2 · ANCA Associated Vasculitis

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on October 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 178,580 shares of its common stock to 33 new employees, consisting of inducement stock options to purchase an aggregate of 36,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 142,580 shares of its common stock. These induceme

Frequently Asked Questions

What are the inducement grants by Travere Therapeutics?

Travere Therapeutics granted inducement equity grants totaling 178,580 shares to 33 new employees.

How many shares were included in the inducement grants?

The inducement grants included 36,000 stock options and 142,580 restricted stock units.

When were the inducement grants announced?

The inducement grants were announced on October 10, 2026.

Why are inducement grants important?

Inducement grants help attract and retain talented employees, supporting company growth.

ShareAdd on Google
Tags: TVTX Travere Therapeutics inducement grants Nasdaq equity grants
Last updated: Oct 12, 2026

Biotech snapshot

Cash runway
$489M liquidity · $0M/mo burn
Low dilution risk
Lead asset
SparsentanPhase 2
ANCA Associated Vasculitis →

Catalyst track record

+68%
best trade around TVTX's most recent catalyst

Peak hindsight return over a 120-day window, across 10 tracked FDA/PDUFA catalysts for TVTX.

See every catalyst's timing & PoA →